T2R16 Inhibitors

Chemical inhibitors of T2R16 include a variety of bitter compounds that function by competitive inhibition at the receptor's ligand-binding domain. Inhibitors like absinthin and amarogentin, recognized for their bitterness, interact directly with T2R16. Absinthin's binding to T2R16 inhibits activation by other bitter stimuli, while amarogentin's attachment to the receptor's active site blocks activation by the receptor's natural ligands. Parthenolide and salicin, both bitter-tasting substances, engage with T2R16's ligand-binding domain in a competitive manner, which inhibits the receptor's signaling capabilities. Similarly, sucrose octaacetate's bitterness allows it to inhibit T2R16 by preventing downstream signaling pathways from being initiated. Magnolol inhibits T2R16 by direct interaction, which inhibits the receptor's signaling mechanism, while hops extract, containing bitter acids like humulones and lupulones, inhibits the receptor by binding to its active sites, thus blocking the signaling pathway of T2R16.